| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |